| ￥1200 | |
| A03842-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to Coagulation factor XIII A |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Coagulation factor XIII A |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of Factor XIIIa expression in human spleen lysate. »
| Target Background | Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. |
| Synonyms | Coagulation factor XIIIa; F13A; F13a1; Fibrin stabilizing factor, A subunit; Fibrinoligase; TGase; Transglutaminase A chain; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
